

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 6.74488783 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.13510701 |
| 3 | intestinal absorption (GO:0050892) | 5.86387343 |
| 4 | melanin biosynthetic process (GO:0042438) | 5.42146856 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.03712451 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03712451 |
| 7 | regulation of cholesterol esterification (GO:0010872) | 5.03044494 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 4.99286742 |
| 9 | phospholipid efflux (GO:0033700) | 4.93006010 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.92968619 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.89827995 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.89827995 |
| 13 | melanin metabolic process (GO:0006582) | 4.86049253 |
| 14 | plasma lipoprotein particle assembly (GO:0034377) | 4.83153192 |
| 15 | reverse cholesterol transport (GO:0043691) | 4.83152440 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 4.81132004 |
| 17 | bile acid and bile salt transport (GO:0015721) | 4.69623440 |
| 18 | urea cycle (GO:0000050) | 4.63408650 |
| 19 | urea metabolic process (GO:0019627) | 4.63408650 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 4.60975495 |
| 21 | angiotensin maturation (GO:0002003) | 4.60457490 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 4.58176956 |
| 23 | negative regulation of sterol transport (GO:0032372) | 4.58176956 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 4.53878287 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 4.53878287 |
| 26 | protein-lipid complex remodeling (GO:0034368) | 4.52612243 |
| 27 | macromolecular complex remodeling (GO:0034367) | 4.52612243 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 4.52612243 |
| 29 | cholesterol efflux (GO:0033344) | 4.51151057 |
| 30 | protein-lipid complex assembly (GO:0065005) | 4.51026701 |
| 31 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.48724472 |
| 32 | regulation of bile acid biosynthetic process (GO:0070857) | 4.47802065 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 4.46921110 |
| 34 | cysteine metabolic process (GO:0006534) | 4.31799862 |
| 35 | flavonoid metabolic process (GO:0009812) | 4.31305268 |
| 36 | drug catabolic process (GO:0042737) | 4.29414215 |
| 37 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.24465260 |
| 38 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.24465260 |
| 39 | amyloid precursor protein catabolic process (GO:0042987) | 4.24022705 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.20490064 |
| 41 | protein localization to endosome (GO:0036010) | 4.18572256 |
| 42 | lipoprotein metabolic process (GO:0042157) | 4.17211067 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 4.16555015 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.13719289 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 4.10011119 |
| 46 | cholesterol homeostasis (GO:0042632) | 4.08470063 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.07730025 |
| 48 | barbed-end actin filament capping (GO:0051016) | 4.07567665 |
| 49 | bile acid metabolic process (GO:0008206) | 4.04870220 |
| 50 | complement activation, alternative pathway (GO:0006957) | 4.03862795 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 4.03573896 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 4.03573896 |
| 53 | tryptophan catabolic process (GO:0006569) | 4.03573896 |
| 54 | kynurenine metabolic process (GO:0070189) | 4.02651051 |
| 55 | bile acid biosynthetic process (GO:0006699) | 4.02495965 |
| 56 | sterol homeostasis (GO:0055092) | 4.01998220 |
| 57 | regulation of protein activation cascade (GO:2000257) | 3.96146685 |
| 58 | glyoxylate metabolic process (GO:0046487) | 3.92430902 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.92277952 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.92277952 |
| 61 | plasma lipoprotein particle organization (GO:0071827) | 3.90549591 |
| 62 | secondary metabolite biosynthetic process (GO:0044550) | 3.89695508 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86812405 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86315059 |
| 65 | protein carboxylation (GO:0018214) | 3.86315059 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 3.80905356 |
| 67 | protein-lipid complex subunit organization (GO:0071825) | 3.77869925 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.77298494 |
| 69 | regulation of complement activation (GO:0030449) | 3.73612862 |
| 70 | pinocytosis (GO:0006907) | 3.72990402 |
| 71 | phospholipid homeostasis (GO:0055091) | 3.71200735 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70591950 |
| 73 | basement membrane organization (GO:0071711) | 3.64545679 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 3.64418636 |
| 75 | cellular glucuronidation (GO:0052695) | 3.60738479 |
| 76 | cholesterol transport (GO:0030301) | 3.59324480 |
| 77 | sterol transport (GO:0015918) | 3.59324480 |
| 78 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.56434166 |
| 79 | protein retention in ER lumen (GO:0006621) | 3.56132079 |
| 80 | regulation of fibrinolysis (GO:0051917) | 3.51899110 |
| 81 | ethanol oxidation (GO:0006069) | 3.50721324 |
| 82 | lysine catabolic process (GO:0006554) | 3.49217506 |
| 83 | lysine metabolic process (GO:0006553) | 3.49217506 |
| 84 | regulation of early endosome to late endosome transport (GO:2000641) | 3.48202533 |
| 85 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.47681228 |
| 86 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.40285241 |
| 87 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.39505882 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.39359340 |
| 89 | killing of cells of other organism (GO:0031640) | 3.33199998 |
| 90 | disruption of cells of other organism (GO:0044364) | 3.33199998 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.33059508 |
| 92 | pentose-phosphate shunt (GO:0006098) | 3.29216441 |
| 93 | heme transport (GO:0015886) | 3.25982726 |
| 94 | drug metabolic process (GO:0017144) | 3.25854333 |
| 95 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.24566234 |
| 96 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.23783061 |
| 97 | hormone catabolic process (GO:0042447) | 3.22929430 |
| 98 | ethanol metabolic process (GO:0006067) | 3.17105491 |
| 99 | aromatic amino acid family metabolic process (GO:0009072) | 3.16583520 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.13637288 |
| 101 | lipid homeostasis (GO:0055088) | 3.13317285 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.12832941 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.12832941 |
| 104 | negative regulation of cell size (GO:0045792) | 3.11147283 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.10983258 |
| 106 | arginine metabolic process (GO:0006525) | 3.10043444 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 3.08672855 |
| 108 | drug transmembrane transport (GO:0006855) | 3.07571452 |
| 109 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.07400139 |
| 110 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.06715038 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 3.06108385 |
| 112 | response to nitrosative stress (GO:0051409) | 3.05838303 |
| 113 | protein maturation by protein folding (GO:0022417) | 3.05754870 |
| 114 | benzene-containing compound metabolic process (GO:0042537) | 3.04233762 |
| 115 | exogenous drug catabolic process (GO:0042738) | 3.04175312 |
| 116 | alpha-amino acid catabolic process (GO:1901606) | 3.02838314 |
| 117 | epoxygenase P450 pathway (GO:0019373) | 3.02564337 |
| 118 | glucocorticoid biosynthetic process (GO:0006704) | 3.01822346 |
| 119 | very long-chain fatty acid metabolic process (GO:0000038) | 3.01798975 |
| 120 | response to peptidoglycan (GO:0032494) | 3.00284688 |
| 121 | tyrosine metabolic process (GO:0006570) | 3.00244844 |
| 122 | adhesion of symbiont to host (GO:0044406) | 2.99901361 |
| 123 | epithelial cell-cell adhesion (GO:0090136) | 2.99543631 |
| 124 | glutamate metabolic process (GO:0006536) | 2.98521071 |
| 125 | amyloid precursor protein metabolic process (GO:0042982) | 2.98474343 |
| 126 | low-density lipoprotein particle clearance (GO:0034383) | 2.98302760 |
| 127 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.95101783 |
| 128 | glucose catabolic process (GO:0006007) | 2.92846265 |
| 129 | positive regulation of receptor recycling (GO:0001921) | 2.88866702 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.88455957 |
| 131 | desmosome organization (GO:0002934) | 2.82591451 |
| 132 | mannose metabolic process (GO:0006013) | 2.80723745 |
| 133 | stress fiber assembly (GO:0043149) | 2.80430966 |
| 134 | regulation of gonadotropin secretion (GO:0032276) | 2.79266022 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76125989 |
| 136 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71323911 |
| 137 | NADPH regeneration (GO:0006740) | 2.71037305 |
| 138 | response to laminar fluid shear stress (GO:0034616) | 2.64443679 |
| 139 | activation of Rac GTPase activity (GO:0032863) | 2.64147002 |
| 140 | modulation by symbiont of host cellular process (GO:0044068) | 2.62453399 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.62046821 |
| 142 | semaphorin-plexin signaling pathway (GO:0071526) | 2.61691238 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.57937488 |
| 144 | hyaluronan catabolic process (GO:0030214) | 2.57672802 |
| 145 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.56787633 |
| 146 | adherens junction assembly (GO:0034333) | 2.56224680 |
| 147 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.55638444 |
| 148 | negative regulation of focal adhesion assembly (GO:0051895) | 2.52914983 |
| 149 | negative regulation of cell junction assembly (GO:1901889) | 2.52914983 |
| 150 | negative regulation of adherens junction organization (GO:1903392) | 2.52914983 |
| 151 | focal adhesion assembly (GO:0048041) | 2.52907347 |
| 152 | cell-substrate adherens junction assembly (GO:0007045) | 2.52907347 |
| 153 | UV protection (GO:0009650) | 2.52828561 |
| 154 | hypotonic response (GO:0006971) | 2.52690785 |
| 155 | cell-substrate junction assembly (GO:0007044) | 2.52235057 |
| 156 | endothelial cell chemotaxis (GO:0035767) | 2.52076235 |
| 157 | skin morphogenesis (GO:0043589) | 2.48779101 |
| 158 | androgen biosynthetic process (GO:0006702) | 2.48540252 |
| 159 | embryonic process involved in female pregnancy (GO:0060136) | 2.48355021 |
| 160 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.46648720 |
| 161 | membrane protein ectodomain proteolysis (GO:0006509) | 2.43853437 |
| 162 | negative regulation of fatty acid transport (GO:2000192) | 2.42130444 |
| 163 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.41486342 |
| 164 | peptidyl-proline hydroxylation (GO:0019511) | 2.41349003 |
| 165 | glucocorticoid metabolic process (GO:0008211) | 2.40708819 |
| 166 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.40688111 |
| 167 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40283601 |
| 168 | modulation by symbiont of host defense response (GO:0052031) | 2.40283601 |
| 169 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40283601 |
| 170 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40283601 |
| 171 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40283601 |
| 172 | modulation by symbiont of host immune response (GO:0052553) | 2.40283601 |
| 173 | apoptotic process involved in morphogenesis (GO:0060561) | 2.39710722 |
| 174 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.39610474 |
| 175 | negative regulation of necroptotic process (GO:0060546) | 2.37770454 |
| 176 | glucose 6-phosphate metabolic process (GO:0051156) | 2.37629121 |
| 177 | regulation of leukocyte degranulation (GO:0043300) | 2.36604852 |
| 178 | cellular response to epinephrine stimulus (GO:0071872) | 2.36555837 |
| 179 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.36376171 |
| 180 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.31497646 |
| 181 | progesterone metabolic process (GO:0042448) | 2.30340130 |
| 182 | response to thyroid hormone (GO:0097066) | 2.29705989 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.28132959 |
| 184 | cortical actin cytoskeleton organization (GO:0030866) | 2.26123147 |
| 185 | regulation of necrotic cell death (GO:0010939) | 2.25896923 |
| 186 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24644683 |
| 187 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.24519868 |
| 188 | positive regulation of nuclease activity (GO:0032075) | 2.24381044 |
| 189 | pigment cell differentiation (GO:0050931) | 2.24029304 |
| 190 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.23107177 |
| 191 | maternal placenta development (GO:0001893) | 2.23058349 |
| 192 | protein hydroxylation (GO:0018126) | 2.22762249 |
| 193 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.22098220 |
| 194 | regulation of necroptotic process (GO:0060544) | 2.21058122 |
| 195 | negative regulation of viral release from host cell (GO:1902187) | 2.19756183 |
| 196 | hemidesmosome assembly (GO:0031581) | 2.18834605 |
| 197 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.18545120 |
| 198 | membrane raft organization (GO:0031579) | 2.18473525 |
| 199 | germinal center formation (GO:0002467) | 2.17909445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.73579789 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21661471 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.67586943 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.02993197 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.76335772 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52660917 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.66526764 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.52214108 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.16717863 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.90494687 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.72002807 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.58906880 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.34696979 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.28799696 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.17394149 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17261494 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16914643 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10228104 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08686592 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04916030 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96017300 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.95570131 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88352618 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84745297 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84694888 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.82694459 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82011111 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80336043 |
| 29 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.79399624 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76812015 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76066535 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75778414 |
| 33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.71772229 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65478500 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.65460235 |
| 36 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64856257 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58718376 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58084890 |
| 39 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57742278 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56887826 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56151987 |
| 42 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.54116466 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.52304867 |
| 44 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.50837798 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48907751 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48652800 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47787040 |
| 48 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.44821766 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44590807 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.39009439 |
| 51 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.37207803 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32551540 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31522836 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.31324339 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29052931 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27039580 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26944945 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26267477 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25229980 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24648365 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24291780 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24133956 |
| 63 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24130222 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22291358 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22186150 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21961775 |
| 67 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.21958125 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20794521 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19062662 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18930957 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18421501 |
| 72 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17803505 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15810813 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15279015 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13911521 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13790262 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13788086 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13701282 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13691942 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13429180 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13272460 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12753822 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11390783 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11144477 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10672548 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09760867 |
| 87 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09497960 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08638433 |
| 89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08630524 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07204685 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06754260 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.06589388 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06254265 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05833512 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05631839 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04794185 |
| 97 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04673407 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04282156 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04282156 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02885512 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02471211 |
| 102 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02233729 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01427220 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00824534 |
| 105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00347224 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00337259 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00171924 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99120475 |
| 109 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98088063 |
| 110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96943361 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96167712 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94185536 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92838748 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90334955 |
| 115 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90028133 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89594248 |
| 117 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88811511 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88648154 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86764483 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86494369 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85961396 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83868734 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83250751 |
| 124 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82732868 |
| 125 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81715496 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80602724 |
| 127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78323221 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78165520 |
| 129 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.77735207 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77549743 |
| 131 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.77196465 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.75267704 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.74663844 |
| 134 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73544056 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73514391 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73125793 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72945805 |
| 138 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72817502 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72163899 |
| 140 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.71915078 |
| 141 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71903629 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71661051 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71627579 |
| 144 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71448281 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.70263728 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67998031 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67029166 |
| 148 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.64883664 |
| 149 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.64830704 |
| 150 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64722814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.06218893 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.35993803 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.02929317 |
| 4 | MP0005365_abnormal_bile_salt | 4.53677087 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 4.24814372 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.10695683 |
| 7 | MP0005171_absent_coat_pigmentation | 4.08427040 |
| 8 | MP0001666_abnormal_nutrient_absorption | 4.00932538 |
| 9 | MP0009840_abnormal_foam_cell | 3.81710438 |
| 10 | MP0003252_abnormal_bile_duct | 3.57802884 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.25821299 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.23688456 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.85757557 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.57083099 |
| 15 | MP0008260_abnormal_autophagy | 2.53727726 |
| 16 | MP0005409_darkened_coat_color | 2.51531885 |
| 17 | MP0004381_abnormal_hair_follicle | 2.51013155 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.47911326 |
| 19 | MP0000015_abnormal_ear_pigmentation | 2.29069639 |
| 20 | MP0003303_peritoneal_inflammation | 2.12892280 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.12397568 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.11362236 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 2.03033151 |
| 24 | MP0005332_abnormal_amino_acid | 2.01421174 |
| 25 | MP0005083_abnormal_biliary_tract | 1.98758531 |
| 26 | MP0004858_abnormal_nervous_system | 1.94871711 |
| 27 | MP0000609_abnormal_liver_physiology | 1.90052097 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.87521719 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.87395393 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.76853088 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.75075264 |
| 32 | MP0004233_abnormal_muscle_weight | 1.72950289 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.72709455 |
| 34 | MP0001849_ear_inflammation | 1.72138760 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.71040350 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.68243820 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.65698524 |
| 38 | MP0008004_abnormal_stomach_pH | 1.61413719 |
| 39 | MP0004510_myositis | 1.58940392 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.54754269 |
| 41 | MP0009278_abnormal_bone_marrow | 1.52297344 |
| 42 | MP0004147_increased_porphyrin_level | 1.52283580 |
| 43 | MP0000371_diluted_coat_color | 1.52050136 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.50760880 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.49951144 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.45230918 |
| 47 | MP0003091_abnormal_cell_migration | 1.44046265 |
| 48 | MP0000858_altered_metastatic_potential | 1.43240772 |
| 49 | MP0003136_yellow_coat_color | 1.43082700 |
| 50 | MP0003868_abnormal_feces_composition | 1.39420862 |
| 51 | MP0003195_calcinosis | 1.37309975 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.33408173 |
| 53 | MP0002075_abnormal_coat/hair_pigmentati | 1.32643166 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.32026350 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31921274 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.29905993 |
| 57 | MP0002254_reproductive_system_inflammat | 1.28219744 |
| 58 | MP0003828_pulmonary_edema | 1.27637377 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.26664746 |
| 60 | MP0004272_abnormal_basement_membrane | 1.24042545 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 1.18855516 |
| 62 | MP0003866_abnormal_defecation | 1.18074569 |
| 63 | MP0000604_amyloidosis | 1.18016032 |
| 64 | MP0003279_aneurysm | 1.14880909 |
| 65 | MP0009697_abnormal_copulation | 1.14668711 |
| 66 | MP0001764_abnormal_homeostasis | 1.14513426 |
| 67 | MP0001186_pigmentation_phenotype | 1.14403023 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.13795158 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.13516376 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.12256204 |
| 71 | MP0000343_altered_response_to | 1.09810545 |
| 72 | MP0009764_decreased_sensitivity_to | 1.07287362 |
| 73 | MP0001873_stomach_inflammation | 1.06702927 |
| 74 | MP0003724_increased_susceptibility_to | 1.05029626 |
| 75 | MP0006054_spinal_hemorrhage | 1.04139355 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.02738060 |
| 77 | MP0000598_abnormal_liver_morphology | 1.01293688 |
| 78 | MP0005501_abnormal_skin_physiology | 1.01027527 |
| 79 | MP0001851_eye_inflammation | 1.00217298 |
| 80 | MP0005375_adipose_tissue_phenotype | 0.99564911 |
| 81 | MP0008469_abnormal_protein_level | 0.99233512 |
| 82 | MP0001663_abnormal_digestive_system | 0.95454463 |
| 83 | MP0000750_abnormal_muscle_regeneration | 0.95097419 |
| 84 | MP0005165_increased_susceptibility_to | 0.94857547 |
| 85 | MP0004947_skin_inflammation | 0.94567890 |
| 86 | MP0003436_decreased_susceptibility_to | 0.93645941 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.93574496 |
| 88 | * MP0005464_abnormal_platelet_physiology | 0.92016461 |
| 89 | MP0000462_abnormal_digestive_system | 0.91337979 |
| 90 | MP0009763_increased_sensitivity_to | 0.90033479 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.89848961 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.88793662 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.88793662 |
| 94 | MP0005330_cardiomyopathy | 0.87964362 |
| 95 | MP0001661_extended_life_span | 0.87677733 |
| 96 | MP0005451_abnormal_body_composition | 0.87530662 |
| 97 | MP0005621_abnormal_cell_physiology | 0.85115009 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.84920275 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.84563400 |
| 100 | MP0001958_emphysema | 0.82568797 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.81689214 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.80930496 |
| 103 | MP0005390_skeleton_phenotype | 0.80097280 |
| 104 | MP0009785_altered_susceptibility_to | 0.80040788 |
| 105 | MP0005166_decreased_susceptibility_to | 0.79100074 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.78630551 |
| 107 | MP0005448_abnormal_energy_balance | 0.77698136 |
| 108 | * MP0009642_abnormal_blood_homeostasis | 0.77483450 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.76845077 |
| 110 | MP0003795_abnormal_bone_structure | 0.76741820 |
| 111 | MP0003634_abnormal_glial_cell | 0.76142733 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.76073046 |
| 113 | MP0006138_congestive_heart_failure | 0.75348701 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.75313021 |
| 115 | MP0000678_abnormal_parathyroid_gland | 0.74623415 |
| 116 | MP0003011_delayed_dark_adaptation | 0.73759930 |
| 117 | MP0001853_heart_inflammation | 0.73617368 |
| 118 | MP0003186_abnormal_redox_activity | 0.73037627 |
| 119 | MP0003329_amyloid_beta_deposits | 0.72812891 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.72699539 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.72167020 |
| 122 | MP0003690_abnormal_glial_cell | 0.71450374 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.71301780 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.70825638 |
| 125 | MP0003075_altered_response_to | 0.70627462 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.70396333 |
| 127 | MP0000751_myopathy | 0.70271660 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.70220421 |
| 129 | MP0003448_altered_tumor_morphology | 0.68265657 |
| 130 | * MP0005025_abnormal_response_to | 0.68134812 |
| 131 | MP0002419_abnormal_innate_immunity | 0.68000518 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.66821376 |
| 133 | MP0006082_CNS_inflammation | 0.66657663 |
| 134 | MP0005174_abnormal_tail_pigmentation | 0.66650250 |
| 135 | MP0005197_abnormal_uvea_morphology | 0.65853073 |
| 136 | MP0002796_impaired_skin_barrier | 0.65821070 |
| 137 | MP0001915_intracranial_hemorrhage | 0.65579727 |
| 138 | MP0005023_abnormal_wound_healing | 0.65111692 |
| 139 | MP0000747_muscle_weakness | 0.64781766 |
| 140 | MP0005058_abnormal_lysosome_morphology | 0.64741822 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.64617631 |
| 142 | MP0005647_abnormal_sex_gland | 0.63887927 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.63541677 |
| 144 | MP0005000_abnormal_immune_tolerance | 0.62626079 |
| 145 | MP0002971_abnormal_brown_adipose | 0.62528942 |
| 146 | MP0005508_abnormal_skeleton_morphology | 0.62170419 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.62095341 |
| 148 | MP0000733_abnormal_muscle_development | 0.61836215 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.61410219 |
| 150 | MP0000249_abnormal_blood_vessel | 0.61147548 |
| 151 | MP0001533_abnormal_skeleton_physiology | 0.61107385 |
| 152 | MP0000627_abnormal_mammary_gland | 0.61041967 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.57736836 |
| 154 | MP0000685_abnormal_immune_system | 0.57341781 |
| 155 | MP0008873_increased_physiological_sensi | 0.57166593 |
| 156 | MP0005334_abnormal_fat_pad | 0.56320101 |
| 157 | MP0005408_hypopigmentation | 0.55211130 |
| 158 | MP0009115_abnormal_fat_cell | 0.54232737 |
| 159 | MP0005266_abnormal_metabolism | 0.54104488 |
| 160 | MP0000490_abnormal_crypts_of | 0.53004918 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.52221108 |
| 162 | MP0002060_abnormal_skin_morphology | 0.52078029 |
| 163 | MP0002132_abnormal_respiratory_system | 0.50369340 |
| 164 | MP0001881_abnormal_mammary_gland | 0.50111511 |
| 165 | MP0005164_abnormal_response_to | 0.48765600 |
| 166 | MP0001835_abnormal_antigen_presentation | 0.48598216 |
| 167 | MP0003878_abnormal_ear_physiology | 0.47754304 |
| 168 | MP0005377_hearing/vestibular/ear_phenot | 0.47754304 |
| 169 | MP0009379_abnormal_foot_pigmentation | 0.46609218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.26462151 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.76342653 |
| 3 | Xanthomatosis (HP:0000991) | 5.53725289 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.44860166 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.39332716 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.30035710 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.02994279 |
| 8 | Hypolipoproteinemia (HP:0010981) | 4.53130381 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.42915459 |
| 10 | Fat malabsorption (HP:0002630) | 4.30505489 |
| 11 | Acanthocytosis (HP:0001927) | 4.10011048 |
| 12 | Vertebral compression fractures (HP:0002953) | 4.04822116 |
| 13 | Complement deficiency (HP:0004431) | 4.04193247 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.02699608 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.93758107 |
| 16 | Epidermoid cyst (HP:0200040) | 3.89463012 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.89133648 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.81561367 |
| 19 | Ileus (HP:0002595) | 3.77580129 |
| 20 | Hyperammonemia (HP:0001987) | 3.74631939 |
| 21 | Protrusio acetabuli (HP:0003179) | 3.71187951 |
| 22 | Hypercholesterolemia (HP:0003124) | 3.65246230 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.62815271 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.55480121 |
| 25 | Malnutrition (HP:0004395) | 3.52823376 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.48242361 |
| 27 | Abnormality of proline metabolism (HP:0010907) | 3.46986596 |
| 28 | Hydroxyprolinuria (HP:0003080) | 3.46986596 |
| 29 | Hyperglycinuria (HP:0003108) | 3.41306709 |
| 30 | Abnormality of complement system (HP:0005339) | 3.27637417 |
| 31 | Joint hemorrhage (HP:0005261) | 3.26779088 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.17301172 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17301172 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 3.16173740 |
| 35 | Premature rupture of membranes (HP:0001788) | 3.11068430 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03988740 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03988740 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03988740 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.00705780 |
| 40 | Ocular albinism (HP:0001107) | 3.00467241 |
| 41 | Poikilocytosis (HP:0004447) | 2.97907364 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.97328482 |
| 43 | Amyloidosis (HP:0011034) | 2.97304265 |
| 44 | Increased connective tissue (HP:0009025) | 2.96984558 |
| 45 | Hypoglycemic coma (HP:0001325) | 2.96294674 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95018113 |
| 47 | Ketosis (HP:0001946) | 2.93322947 |
| 48 | Distal upper limb amyotrophy (HP:0007149) | 2.92324083 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.92324083 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.92286167 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.85356726 |
| 52 | White forelock (HP:0002211) | 2.84795704 |
| 53 | Right ventricular cardiomyopathy (HP:0011663) | 2.81643795 |
| 54 | Myocardial infarction (HP:0001658) | 2.80940921 |
| 55 | Esophageal varix (HP:0002040) | 2.80827256 |
| 56 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79213190 |
| 57 | Steatorrhea (HP:0002570) | 2.76678452 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.74759850 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72949614 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.71070686 |
| 61 | Polycythemia (HP:0001901) | 2.70831718 |
| 62 | Cerebral aneurysm (HP:0004944) | 2.67857677 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64967872 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.64807247 |
| 65 | J-shaped sella turcica (HP:0002680) | 2.63620780 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.57845213 |
| 67 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.55888452 |
| 68 | Increased mean platelet volume (HP:0011877) | 2.53919257 |
| 69 | Spontaneous abortion (HP:0005268) | 2.51646947 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.49822477 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.49822477 |
| 72 | Hand muscle atrophy (HP:0009130) | 2.48903739 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.48692948 |
| 74 | Vascular calcification (HP:0004934) | 2.45580022 |
| 75 | Flat acetabular roof (HP:0003180) | 2.44901750 |
| 76 | Hyperacusis (HP:0010780) | 2.42394083 |
| 77 | Short nail (HP:0001799) | 2.42057159 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.39694760 |
| 79 | Hyperglycinemia (HP:0002154) | 2.39601082 |
| 80 | Gingival bleeding (HP:0000225) | 2.39185982 |
| 81 | Metabolic acidosis (HP:0001942) | 2.38939041 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 2.37298659 |
| 83 | Skin nodule (HP:0200036) | 2.35742526 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.35560179 |
| 85 | Patchy hypopigmentation of hair (HP:0011365) | 2.35007741 |
| 86 | Late onset (HP:0003584) | 2.34734853 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.34394313 |
| 88 | Broad face (HP:0000283) | 2.29949046 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27506129 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.26975449 |
| 91 | Loss of speech (HP:0002371) | 2.26161096 |
| 92 | Reticulocytosis (HP:0001923) | 2.26076250 |
| 93 | Iris hypopigmentation (HP:0007730) | 2.25691807 |
| 94 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24174912 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.23459851 |
| 96 | Glomerulonephritis (HP:0000099) | 2.21011833 |
| 97 | Ketoacidosis (HP:0001993) | 2.20860202 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 2.18839793 |
| 99 | Cervical subluxation (HP:0003308) | 2.17156069 |
| 100 | Peripheral hypomyelination (HP:0007182) | 2.15388078 |
| 101 | Abdominal distention (HP:0003270) | 2.13727600 |
| 102 | Hypopigmentation of the fundus (HP:0007894) | 2.11190246 |
| 103 | Spastic diplegia (HP:0001264) | 2.10749466 |
| 104 | Neurofibrillary tangles (HP:0002185) | 2.10595760 |
| 105 | Spinal cord compression (HP:0002176) | 2.10095662 |
| 106 | Pancreatitis (HP:0001733) | 2.09244766 |
| 107 | Wormian bones (HP:0002645) | 2.07513246 |
| 108 | Cholelithiasis (HP:0001081) | 2.07503105 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.06515379 |
| 110 | Elbow flexion contracture (HP:0002987) | 2.05618588 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 2.05198433 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04913939 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 2.04913939 |
| 114 | Interstitial pulmonary disease (HP:0006530) | 2.04583933 |
| 115 | Ulnar bowing (HP:0003031) | 2.04109044 |
| 116 | Mesangial abnormality (HP:0001966) | 2.03639244 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.03590077 |
| 118 | Cholecystitis (HP:0001082) | 2.03270232 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 2.03270232 |
| 120 | Delayed CNS myelination (HP:0002188) | 2.02294955 |
| 121 | Hypoplasia of the iris (HP:0007676) | 2.01992233 |
| 122 | Eczematoid dermatitis (HP:0000976) | 2.01075366 |
| 123 | Nephritis (HP:0000123) | 2.00472516 |
| 124 | Pustule (HP:0200039) | 2.00144398 |
| 125 | Peritonitis (HP:0002586) | 1.99952502 |
| 126 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99748312 |
| 127 | Abnormal platelet function (HP:0011869) | 1.98346061 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.98346061 |
| 129 | Thrombophlebitis (HP:0004418) | 1.98082370 |
| 130 | Heterochromia iridis (HP:0001100) | 1.97687772 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.97524761 |
| 132 | Cellulitis (HP:0100658) | 1.97475865 |
| 133 | Pigmentary retinal degeneration (HP:0001146) | 1.96924854 |
| 134 | Relative macrocephaly (HP:0004482) | 1.95425724 |
| 135 | Increased serum ferritin (HP:0003281) | 1.95323014 |
| 136 | Lower limb amyotrophy (HP:0007210) | 1.93108379 |
| 137 | Blue sclerae (HP:0000592) | 1.92866442 |
| 138 | Sensorimotor neuropathy (HP:0007141) | 1.92248403 |
| 139 | Coxa vara (HP:0002812) | 1.91075115 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89750605 |
| 141 | Ragged-red muscle fibers (HP:0003200) | 1.89457606 |
| 142 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89248380 |
| 143 | Mucopolysacchariduria (HP:0008155) | 1.89248380 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88414445 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88414445 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88414445 |
| 147 | Spastic paraparesis (HP:0002313) | 1.87977887 |
| 148 | Menorrhagia (HP:0000132) | 1.87086905 |
| 149 | Abnormal ossification of hand bones (HP:0005921) | 1.86808572 |
| 150 | Nonimmune hydrops fetalis (HP:0001790) | 1.86561382 |
| 151 | Nuclear cataract (HP:0100018) | 1.86488451 |
| 152 | Abnormality of vitamin metabolism (HP:0100508) | 1.84773847 |
| 153 | Nephrolithiasis (HP:0000787) | 1.84612170 |
| 154 | Blue irides (HP:0000635) | 1.84365515 |
| 155 | Growth hormone excess (HP:0000845) | 1.83025832 |
| 156 | Gastrointestinal dysmotility (HP:0002579) | 1.82897549 |
| 157 | Cupped ribs (HP:0000887) | 1.82531599 |
| 158 | Bone pain (HP:0002653) | 1.82525745 |
| 159 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81504778 |
| 160 | Trismus (HP:0000211) | 1.81100818 |
| 161 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80645875 |
| 162 | Paraparesis (HP:0002385) | 1.79974240 |
| 163 | Irritability (HP:0000737) | 1.79679499 |
| 164 | Purpura (HP:0000979) | 1.79421720 |
| 165 | Hypertriglyceridemia (HP:0002155) | 1.79390050 |
| 166 | Abnormality of macrophages (HP:0004311) | 1.79038016 |
| 167 | Thin bony cortex (HP:0002753) | 1.77757962 |
| 168 | Axonal loss (HP:0003447) | 1.77197810 |
| 169 | Nausea (HP:0002018) | 1.76773630 |
| 170 | Spinal rigidity (HP:0003306) | 1.74846313 |
| 171 | Aneurysm (HP:0002617) | 1.74736228 |
| 172 | Asymmetry of the thorax (HP:0001555) | 1.74715400 |
| 173 | Fragile skin (HP:0001030) | 1.74709283 |
| 174 | Stridor (HP:0010307) | 1.73595053 |
| 175 | Fatigue (HP:0012378) | 1.73439308 |
| 176 | Hypoglycemic seizures (HP:0002173) | 1.72662789 |
| 177 | Bulbar palsy (HP:0001283) | 1.72244942 |
| 178 | Pathologic fracture (HP:0002756) | 1.72202336 |
| 179 | Abnormality of the thoracic spine (HP:0100711) | 1.71873829 |
| 180 | Difficulty climbing stairs (HP:0003551) | 1.71235390 |
| 181 | Hepatosplenomegaly (HP:0001433) | 1.70740405 |
| 182 | Hypochromic microcytic anemia (HP:0004840) | 1.70580113 |
| 183 | Generalized amyotrophy (HP:0003700) | 1.70309193 |
| 184 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.69061338 |
| 185 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68483083 |
| 186 | Asymmetric septal hypertrophy (HP:0001670) | 1.67266438 |
| 187 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67167542 |
| 188 | Flattened epiphyses (HP:0003071) | 1.67130511 |
| 189 | Abnormality of the umbilical cord (HP:0010881) | 1.66985449 |
| 190 | Deformed sella turcica (HP:0002681) | 1.65926765 |
| 191 | Mitral regurgitation (HP:0001653) | 1.64827008 |
| 192 | Mitral stenosis (HP:0001718) | 1.64753028 |
| 193 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.64509269 |
| 194 | Petechiae (HP:0000967) | 1.64467948 |
| 195 | Hyperparathyroidism (HP:0000843) | 1.63482553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.27969357 |
| 2 | MST1R | 3.67881681 |
| 3 | PRPF4B | 3.49580336 |
| 4 | NME2 | 3.44246882 |
| 5 | FRK | 3.38462759 |
| 6 | RIPK1 | 3.07427039 |
| 7 | BCKDK | 2.77827025 |
| 8 | FGFR4 | 2.62160909 |
| 9 | PTK6 | 2.61751153 |
| 10 | EPHB1 | 2.56382770 |
| 11 | LMTK2 | 2.46473209 |
| 12 | GRK6 | 2.44078527 |
| 13 | TAOK2 | 2.39485786 |
| 14 | PKN2 | 2.26736374 |
| 15 | TRIB3 | 2.18658197 |
| 16 | SMG1 | 2.17742703 |
| 17 | MST4 | 2.17656744 |
| 18 | PRKG2 | 2.15658514 |
| 19 | SIK1 | 2.15409605 |
| 20 | TYK2 | 1.93656112 |
| 21 | MAP2K2 | 1.82440930 |
| 22 | TAOK3 | 1.77855359 |
| 23 | TBK1 | 1.74212588 |
| 24 | MAP3K10 | 1.59430794 |
| 25 | MET | 1.58890067 |
| 26 | KDR | 1.53348766 |
| 27 | MAP4K1 | 1.50533712 |
| 28 | MAPK11 | 1.46370627 |
| 29 | STK10 | 1.43630262 |
| 30 | FLT3 | 1.43077594 |
| 31 | CSK | 1.42065346 |
| 32 | ARAF | 1.40022657 |
| 33 | CDK12 | 1.34217626 |
| 34 | RIPK4 | 1.30387385 |
| 35 | TTN | 1.29596125 |
| 36 | MAP3K11 | 1.27432740 |
| 37 | EPHA2 | 1.26450509 |
| 38 | PRKD2 | 1.20934836 |
| 39 | MAP2K3 | 1.19423968 |
| 40 | BMX | 1.18110942 |
| 41 | MYLK | 1.16318895 |
| 42 | LRRK2 | 1.15517586 |
| 43 | PTK2 | 1.12400116 |
| 44 | TGFBR2 | 1.10436529 |
| 45 | PAK4 | 1.07456520 |
| 46 | IRAK4 | 0.98915929 |
| 47 | PRKAA2 | 0.98657894 |
| 48 | LIMK1 | 0.97034181 |
| 49 | CDC42BPA | 0.95598635 |
| 50 | MAP3K7 | 0.95426149 |
| 51 | MAP3K6 | 0.93674674 |
| 52 | SCYL2 | 0.91828213 |
| 53 | JAK1 | 0.91118131 |
| 54 | JAK2 | 0.90706694 |
| 55 | TIE1 | 0.90393355 |
| 56 | JAK3 | 0.89681862 |
| 57 | MAP2K6 | 0.89445259 |
| 58 | PRKD3 | 0.89179257 |
| 59 | MOS | 0.88443433 |
| 60 | MAP3K3 | 0.87377515 |
| 61 | MAP3K2 | 0.85896545 |
| 62 | MARK2 | 0.84630280 |
| 63 | MATK | 0.84462586 |
| 64 | IRAK2 | 0.83250510 |
| 65 | MAPKAPK3 | 0.82854005 |
| 66 | LATS2 | 0.82583339 |
| 67 | IKBKE | 0.82320148 |
| 68 | ERBB4 | 0.81428964 |
| 69 | NEK9 | 0.81302922 |
| 70 | BLK | 0.80688399 |
| 71 | MTOR | 0.80535301 |
| 72 | MAP3K8 | 0.77482039 |
| 73 | RPS6KB2 | 0.77032612 |
| 74 | ERBB2 | 0.76730962 |
| 75 | MAP3K14 | 0.76707854 |
| 76 | ILK | 0.76420156 |
| 77 | ZAP70 | 0.74103285 |
| 78 | RPS6KA2 | 0.73719181 |
| 79 | CDK7 | 0.73136955 |
| 80 | MAP2K1 | 0.72835983 |
| 81 | KIT | 0.72274212 |
| 82 | EEF2K | 0.71356084 |
| 83 | MAP3K1 | 0.71122382 |
| 84 | NTRK1 | 0.67902320 |
| 85 | CSF1R | 0.67324763 |
| 86 | TESK1 | 0.67307830 |
| 87 | MAP3K13 | 0.67251039 |
| 88 | BTK | 0.67208535 |
| 89 | EPHB2 | 0.66698467 |
| 90 | BRAF | 0.66020434 |
| 91 | ITK | 0.64921298 |
| 92 | PIK3CG | 0.64158642 |
| 93 | CDK6 | 0.63164618 |
| 94 | INSRR | 0.60097189 |
| 95 | TESK2 | 0.59948862 |
| 96 | PIK3CA | 0.59090417 |
| 97 | MAPK4 | 0.58862322 |
| 98 | SIK3 | 0.58739130 |
| 99 | DDR2 | 0.57192837 |
| 100 | TAOK1 | 0.56060769 |
| 101 | IRAK3 | 0.54738653 |
| 102 | RPS6KL1 | 0.53255606 |
| 103 | RPS6KC1 | 0.53255606 |
| 104 | GRK1 | 0.52858942 |
| 105 | NUAK1 | 0.52635167 |
| 106 | PDPK1 | 0.52214098 |
| 107 | DYRK1B | 0.51895725 |
| 108 | LATS1 | 0.51384617 |
| 109 | PRKD1 | 0.49270105 |
| 110 | DMPK | 0.48547755 |
| 111 | STK38 | 0.47895462 |
| 112 | MARK3 | 0.47317465 |
| 113 | HIPK2 | 0.46990277 |
| 114 | STK3 | 0.46909461 |
| 115 | PIM2 | 0.46402163 |
| 116 | ABL2 | 0.46251405 |
| 117 | KSR2 | 0.44907835 |
| 118 | GSK3A | 0.44845010 |
| 119 | TGFBR1 | 0.43778370 |
| 120 | ICK | 0.43526657 |
| 121 | PDGFRB | 0.42902977 |
| 122 | MAPKAPK2 | 0.42497335 |
| 123 | FGFR3 | 0.42162206 |
| 124 | RET | 0.41878487 |
| 125 | TRPM7 | 0.41648195 |
| 126 | PAK1 | 0.40762403 |
| 127 | PRKACG | 0.40187545 |
| 128 | CDK8 | 0.38799392 |
| 129 | CAMK1D | 0.38775480 |
| 130 | FGR | 0.38683223 |
| 131 | EPHA3 | 0.37562551 |
| 132 | DAPK1 | 0.37186158 |
| 133 | AKT2 | 0.37017306 |
| 134 | MAPK12 | 0.36568074 |
| 135 | ACVR1B | 0.36479974 |
| 136 | ROCK2 | 0.35535060 |
| 137 | PDK1 | 0.34996455 |
| 138 | EGFR | 0.34853828 |
| 139 | PRKCQ | 0.34662506 |
| 140 | FER | 0.34564965 |
| 141 | RAF1 | 0.34375678 |
| 142 | CAMK2G | 0.33873144 |
| 143 | IGF1R | 0.33226425 |
| 144 | TEC | 0.32664205 |
| 145 | PDK2 | 0.32637240 |
| 146 | PDGFRA | 0.32606621 |
| 147 | CHUK | 0.31645843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32028092 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17669365 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09962618 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.03583338 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.97070997 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.77455601 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55341617 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40414138 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40139763 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25926111 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23461642 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.21714797 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.13516125 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.08128836 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06773526 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03674211 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.02549873 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 2.02481749 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01931738 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00888545 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93812456 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.91111461 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.87482195 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.86979781 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86611542 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85080189 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79182114 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.73701960 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70895303 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70732777 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70406377 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.68660136 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68517096 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68175492 |
| 35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.65147435 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.63115309 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.62323309 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61734291 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61104550 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.59561988 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53902232 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52121159 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.48468529 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47481940 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43093591 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41705729 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41217626 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39179024 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38990095 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.34792874 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33947953 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.32890524 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31639477 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.29311134 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27856533 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27609556 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23490820 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23055523 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22066378 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20389647 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19889246 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17543371 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16038744 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 1.15939777 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15907810 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15063812 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14414626 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12376362 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 1.11293141 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10860528 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 1.10692276 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 1.10533555 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10026382 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 1.10002367 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 1.09869141 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09264430 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08722098 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08051928 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07639680 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05632215 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05620801 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05224183 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03775285 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01453512 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00989947 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00949754 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00235300 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00052891 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97994788 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97938111 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.97108505 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96257513 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95013828 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94019236 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.93457880 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92747878 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91446512 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.91133275 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91061308 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.90819864 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88765774 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.88430187 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88130076 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87560574 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85537376 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85474008 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84661144 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83295233 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82419384 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82292628 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81907682 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81222216 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80680239 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80419026 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79997190 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78186929 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75619450 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75063894 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.74013117 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73594157 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72873659 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70701902 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70342370 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70122500 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68682950 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66303208 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65055460 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64829253 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.64334157 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.63257163 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63219268 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.63100870 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.63072761 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62317527 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61932638 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61896302 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61805586 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61041672 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60046150 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59692890 |
| 141 | Measles_Homo sapiens_hsa05162 | 0.59363597 |
| 142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57105124 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54132663 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54043919 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53209152 |
| 146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50632732 |
| 147 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48603929 |
| 148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48471731 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47541099 |
| 150 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47298391 |
| 151 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38901843 |
| 152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38514768 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37004408 |
| 154 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29803424 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28006563 |
| 156 | Insulin resistance_Homo sapiens_hsa04931 | 0.26494224 |
| 157 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22500094 |
| 158 | Pertussis_Homo sapiens_hsa05133 | 0.19830057 |
| 159 | Hepatitis C_Homo sapiens_hsa05160 | 0.17052166 |
| 160 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15971147 |
| 161 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15717359 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14694170 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.11511359 |
| 164 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09151110 |
| 165 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09135233 |
| 166 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08640578 |
| 167 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06728545 |
| 168 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06404912 |
| 169 | Amoebiasis_Homo sapiens_hsa05146 | 0.05905135 |
| 170 | Legionellosis_Homo sapiens_hsa05134 | 0.05627823 |
| 171 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05031343 |
| 172 | Leishmaniasis_Homo sapiens_hsa05140 | 0.05002823 |
| 173 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.03592888 |
| 174 | Bladder cancer_Homo sapiens_hsa05219 | 0.03312765 |
| 175 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.01687691 |
| 176 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.01383901 |
| 177 | Prion diseases_Homo sapiens_hsa05020 | 0.01182921 |

